Clinical Trials in Detroit

Showing 7281-7300 of 19,719 trials

Expanded Access Program of Surufatinib

NCT04814732

This treatment protocol is intended to provide early access of surufatinib to patients with locally advanced or metastatic NETs for whom, in the opinion of their treating physician, other treatment options or surufatinib clinical trials in this indication are unsuitable. This EAP is currently available in the US only.

Neuroendocrine Tumors

Hutchmed

Denver, Colorado, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +8 more locations

TERMINATEDNA< 1 mile

The Pristine Post-Market Study

NCT05228132

This is a prospective, multi-center, single-arm study designed to assess the safety and performance of the Pristine™ Long-Term Hemodialysis Catheter.

Kidney Failure, ChronicHemodialysis ComplicationHemodialysis Catheter Infection+3 more

C. R. Bard142 participantsStarted May 2022

Dothan, Alabama, United States • New Haven, Connecticut, United States • Shreveport, Louisiana, United States +3 more locations

Expanded Access Program of Surufatinib

The Pristine Post-Market Study

Find Trials by Condition in Detroit

A Study of Olaparib and Durvalumab in Prostate Cancer

Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration

BI 894999 First in Human Dose Finding Study in Advanced Malignancies

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Safety and Effectiveness Study of the Zenflow Spring System

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection